Molecules 2009, 14
3607
left a semisolid which was crystallized from ethyl acetate to give white crystals (1.6 g, 40%), m.p.
1
186-189 °C; IR (KBr): υmax 1,672, 1,499, 1,452, 1,275, 1,132, 933, 755 cm-1; H-NMR (CDCl3): δ
3.05-4.75 (m, 24H), 6.96-7.16 (m, 6H), 7.25-7.40 (m, 12H).
4,7,13,16,20,23-Hexaoxa-1,10-diaza-19(1,2)24(1,2)-dibenzabicyclo[8.8.6]tetracosaphane (VII): To a
solution of diamide VI (0.2 g, 0.4 mmol) in THF (2 mL) was added borane in THF (1 M, 2 mL,
2 mmol), and the mixture was heated under reflux for 2 hrs, cooled and water (0.5 mL) carefully added
followed by aqueous HCl (6 M, 4 mL). The solution was concentrated in vacuo and the resulting
yellow solution was brought to pH 8 with aqueous LiOH. The aqueous layer was extracted with
chloroform and dried over sodium sulfate. Removal of the solvent yielded a yellow oil which was
triturated with ethyl acetate to give a white powder, m.p.141-143 °C; IR (KBr): υmax 1,593, 1,505,
1
1,449, 1,341, 1,250, 1,230, 1,135, 1,115, 1,056, 975, 940, 732 cm-1 ; H-NMR (CDCl3): δ 3.12 (m,
4H), 3.54 (m, 16H), 3.81 (m, 4H), 4.37 (s, 4H, 2CH21, 2CH22), 6.92 (m, 8H, aromatic).
195,245-Dibromo-4,7,13,16,20,23-hexaoxa-1,10-diaza-19(1,2)24(1,2)-dibenzabicyclo[8.8.6]tetra-
cosaphane (VIII): To a stirred solution of diamine VII (116 mg, 0.25 mmol) in CH2Cl2 (5 mL) kept at
-78 °C was added portion-wise 2,4,4,6-tetrabromo-2,5-cyclohexadien-1-one (0.25 g, 0.61 mmol). The
mixture was allowed to warm to room temperature and stirred overnight. The resulting yellow solution
was extracted with aqueous NaOH (2 N, 10 mL), water and the organic layer was dried over sodium
sulfate. Removal of the solvent afforded a yellow oil which was chromatographed using silica gel and
methylene chloride and methanol (up to 5%) to give white solid which was recrystallized from ethyl
acetate to yield white crystals (31 mg, 20 %), m.p. 204-206 °C; IR (KBr): υmax 1,580, 1,489, 1,232,
1
1,125, 959, 848, 817 cm-1; H-NMR (CDCl3): δ 3.09-3.16 (m, 4H), 3.36-3.42 (m, 4H), 3.46-3.52 (m.
4H), 3.58-3.66 (m, 8H), 3.76-3.83 (m, 4H), 4.48 (s, 4H, 2CH21, 2CH22), 6.78 (d, J = 8.0 Hz, 2H, 193-H,
243-H), 7.04 (dd, J = 8.0 and 2.4 Hz, 2H, 194-H, 244-H), 7.06 (d, J = 2.4 Hz, 2H, 196-H, 246-H); m/z
(FAB) 651 (M+Na+).
15-Bromo-2,5,10,13-tetraoxa-7,16-diaza-1(1,2),6(1,2)-benzenecyclohexadecaphane (IX): To a stirred
solution of diamine V (150 mg, 0.4 mmol) and pyridine (98 mg, 1.2 mmol) in CH2Cl2 (10 mL) and
kept at -78 °C was added slowly 0.78 M bromine solution in CH2Cl2 (1.3 mL). The mixture was
allowed to warm to room temperature. The reaction mixture was washed with aqueous Na2CO3 and
dried over sodium sulfate. Removal of the solvent yielded a residue which was chromatographed on a
TLC plate (200 µm layer of silica gel IB-F, 1% CH3OH in CH2Cl2 as solvent) to give two major
products: the monobromo-derivative IX (22 mg, 13%), m.p. 158-161 °C; IR (KBr): υmax 3,405, 1,603,
1
1,520, 1,453, 1,261, 1,202, 1,141, 1,096, 942, 838, 799, 724 cm-1; H-NMR (CDCl3): δ 3.31 (m, 4H,
8-CH2, 15-CH2), 3.60 (s, 4H, 11-CH2, 12-CH2), 3.70 (m, 4H, 9-CH2, 14-CH2), 4.36 (m, 4H, 3-CH2,
4-CH2), 4.76 (br s, 2H, NH), 6.44 (d, J = 8.8 Hz, 1H, 13-H), 6.61 (d, J = 7.5 Hz, 1H, 63-H), 6.68 (t,
J = 7.5 Hz, 1H, 65-H), 6.78 (d, J = 7.5 Hz, 1H, 66-H), 6.86 (d, J = 2.0 Hz, 1H, 16-H), 6.90 (t,
J = 7.5 Hz, 1H, 64-H), 6.98 (dd, J = 2 and 8.7 Hz, 1H, 14-H); and the dibromo derivative X (20 mg,
10%), m.p. 210-214 °C; IR (KBr): υmax 3,405, 1,598, 1,509, 1,463, 1,406, 1,346, 1,217, 1,203, 1,146,
1
1,097, 939, 843, 794 cm-1; H-NMR (CDCl3): δ 3.29 (q, J = 5 Hz, 4H, 8-CH2, 15-CH2), 3.60 (s, 4H,
11-CH2, 12-CH2), 3.69 (t, J = 5 Hz, 4H, 9-CH2, 14-CH2), 4.33 (s, 4H, 3-CH2, 4-CH2), 4.73 (br t,